The story of Sildenafil presents a interesting case for stakeholders in the drug sector. While initially a blockbuster success, generating billions, the patent end and the subsequent arrival of cheaper alternatives https://pharma516030.post-blogs.com/62655024/sildenafil-and-the-pharmaceutical-industry-a-hazardous-bet